GlycoForm is a biotechnology company with a core expertise and intellectual property in sugar chemistry and protein glycosylation.
Latest News

12 February 2008

New Consortium announces Significant Grant Funding of Anaemia product programme.

View all news

Next Event

11 September 2008 - 12 September 2008

Glycomics: from Biology to Therapeutics - Royal Society London

View all events

GLY510Protein glycosylation

GLY510 is a novel synthetic glycoprotein designed for the treatment of anaemia.

Monoclonal AntibodiesCurrent programmes

GlycoForm is focusing its efforts on the development of partnerships and competencies for the clinical exploitation of monoclonal antibodies (mAb) or products derived from them.

Glyco-SeSProdrug targetting

GlycoForm's Glyco-SeS technology utilises the properties of selenium and sulfur compounds to ligate sugars to proteins through disulfide bonds.